246 related articles for article (PubMed ID: 25164613)
1. Pancreatic enzyme replacement therapy (PERT) for malabsorption in patients with metastatic pancreatic cancer.
Landers A; Muircroft W; Brown H
BMJ Support Palliat Care; 2016 Mar; 6(1):75-9. PubMed ID: 25164613
[TBL] [Abstract][Full Text] [Related]
2. Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis.
Domínguez-Muñoz JE; Nieto-Garcia L; López-Díaz J; Lariño-Noia J; Abdulkader I; Iglesias-Garcia J
BMC Cancer; 2018 May; 18(1):534. PubMed ID: 29728096
[TBL] [Abstract][Full Text] [Related]
3. Exocrine pancreatic insufficiency following esophagectomy.
Huddy JR; Macharg FM; Lawn AM; Preston SR
Dis Esophagus; 2013 Aug; 26(6):594-7. PubMed ID: 23199208
[TBL] [Abstract][Full Text] [Related]
4. Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients.
Barkin JA; Westermann A; Hoos W; Moravek C; Matrisian L; Wang H; Shemanski L; Barkin JS; Rahib L
Pancreas; 2019 Jul; 48(6):780-786. PubMed ID: 31210656
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of pancreatic enzyme replacement therapy for malabsorption in advanced pancreatic cancer, a pilot study.
Landers A; Brown H; Strother M
Palliat Care; 2019; 12():1178224218825270. PubMed ID: 30799929
[TBL] [Abstract][Full Text] [Related]
6. Contribution of pancreatic enzyme replacement therapy to survival and quality of life in patients with pancreatic exocrine insufficiency.
Layer P; Kashirskaya N; Gubergrits N
World J Gastroenterol; 2019 May; 25(20):2430-2441. PubMed ID: 31171887
[TBL] [Abstract][Full Text] [Related]
7. The use of pancreatic enzyme replacement therapy in patients with a diagnosis of chronic pancreatitis and pancreatic cancer in the US is infrequent and inconsistent.
Forsmark CE; Tang G; Xu H; Tuft M; Hughes SJ; Yadav D
Aliment Pharmacol Ther; 2020 May; 51(10):958-967. PubMed ID: 32249970
[TBL] [Abstract][Full Text] [Related]
8. Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer.
Roeyen G; Berrevoet F; Borbath I; Geboes K; Peeters M; Topal B; Van Cutsem E; Van Laethem JL
ESMO Open; 2022 Feb; 7(1):100386. PubMed ID: 35124465
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic enzyme replacement therapy following surgery for pancreatic cancer: An exploration of patient self-management.
Dunleavy L; Al-Mukhtar A; Halliday V
Clin Nutr ESPEN; 2018 Aug; 26():97-103. PubMed ID: 29908691
[TBL] [Abstract][Full Text] [Related]
10. Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study.
Roberts KJ; Bannister CA; Schrem H
Pancreatology; 2019 Jan; 19(1):114-121. PubMed ID: 30385188
[TBL] [Abstract][Full Text] [Related]
11. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
Kuhn RJ; Gelrud A; Munck A; Caras S
Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085
[TBL] [Abstract][Full Text] [Related]
12. Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy.
Roberts KJ; Schrem H; Hodson J; Angelico R; Dasari BVM; Coldham CA; Marudanayagam R; Sutcliffe RP; Muiesan P; Isaac J; Mirza DF
HPB (Oxford); 2017 Oct; 19(10):859-867. PubMed ID: 28711377
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic Enzyme Replacement Therapy in Patients with Non-pancreatic Digestive Conditions: A Nationwide Claims Analysis.
Phillips AE; Tang G; Wang X; Forsmark CE; Yadav D
Dig Dis Sci; 2023 May; 68(5):1754-1761. PubMed ID: 36370243
[TBL] [Abstract][Full Text] [Related]
14. Enzyme replacement in advanced pancreatic cancer: patient perceptions.
Landers A; McKenzie C; Pitama SG; Brown H
BMJ Support Palliat Care; 2023 Oct; 13(e1):e122-e128. PubMed ID: 32201370
[TBL] [Abstract][Full Text] [Related]
15. A Multicenter Open-Label Randomized Controlled Trial of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic Cancer.
Saito T; Nakai Y; Isayama H; Hirano K; Ishigaki K; Hakuta R; Takeda T; Saito K; Umefune G; Akiyama D; Watanabe T; Takagi K; Takahara N; Hamada T; Uchino R; Mizuno S; Mouri D; Yagioka H; Kogure H; Togawa O; Matsubara S; Ito Y; Yamamoto N; Tada M; Koike K
Pancreas; 2018 Aug; 47(7):800-806. PubMed ID: 29851751
[TBL] [Abstract][Full Text] [Related]
16. Real-World Patient Experience With Pancreatic Enzyme Replacement Therapy in the Treatment of Exocrine Pancreatic Insufficiency.
Barkin JA; Harb D; Kort J; Barkin JS
Pancreas; 2024 Jan; 53(1):e16-e21. PubMed ID: 38039440
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of pancreatic exocrine insufficiency.
Nikfarjam M; Wilson JS; Smith RC;
Med J Aust; 2017 Aug; 207(4):161-165. PubMed ID: 28814218
[TBL] [Abstract][Full Text] [Related]
18. Impact of pancreatic enzyme replacement therapy on short- and long-term outcomes in advanced pancreatic cancer: meta-analysis of randomized controlled trials.
Ammar K; Leeds JS; Ratnayake CB; Sen G; French JJ; Nayar M; Oppong KW; Loveday BP; Pandanaboyana S
Expert Rev Gastroenterol Hepatol; 2021 Aug; 15(8):941-948. PubMed ID: 33522321
[No Abstract] [Full Text] [Related]
19. Gut microbiome as a response marker for pancreatic enzyme replacement therapy in a porcine model of exocrine pancreas insufficiency.
Ritz S; Hahn D; Wami HT; Tegelkamp K; Dobrindt U; Schnekenburger J
Microb Cell Fact; 2020 Dec; 19(1):221. PubMed ID: 33272255
[TBL] [Abstract][Full Text] [Related]
20. Maldigestion from pancreatic exocrine insufficiency.
Pongprasobchai S
J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():99-102. PubMed ID: 24251713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
